Fingerprint
Dive into the research topics of 'Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability–high/mismatch repair–deficient metastatic colorectal cancer: KEYNOTE-164'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically